KD Logo

Neogenomics Inc. [NEO] Shares Fall Approximately -20.90% Over the Year

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Neogenomics Inc. shares valued at $16,511 were sold by Olivo Alicia C on May 15 ’24. At $15.74 per share, Olivo Alicia C sold 1,049 shares. The insider’s holdings dropped to 44,867 shares worth approximately $0.59 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Also, TETRAULT LYNN A. sold 6,112 shares, netting a total of over 97,579 in proceeds. Following the sale of shares at $15.97 each, the insider now holds 50,062 shares.

Before that, Olivo Alicia C had sold 2,587 shares from its account. In a trade valued at $38,713, the General Counsel traded Neogenomics Inc. shares for $14.96 each. Upon closing the transaction, the insider’s holdings decreased to 2,587 shares, worth approximately $0.46 million.

Analysts at BTIG Research resumed the stock at ‘”a Buy”‘ outlook in a report released in late December. As of August 21, 2023, Stephens has increased its “an Equal-weight” rating to a “an Overweight” for NEO. Earlier on May 16, 2023, Raymond James downgraded its rating. Their new recommendation was “a Mkt perform” for NEO stock which previously was a “an Outperform”.

Analyzing NEO Stock Performance

During the last five days, there has been a drop of approximately -6.21%. Over the course of the year, Neogenomics Inc. shares have dropped approximately -18.85%. Shares of the company reached a 52-week high of $17.49 on 02/23/24 and a 52-week low of $13.02 on 06/06/24. A 50-day SMA is recorded $14.50, while a 200-day SMA reached $15.22. Nevertheless, trading volume fell to 0.97 million shares from 0.68 million shares the previous day.

Support And Resistance Levels for Neogenomics Inc. (NEO)

According to the 24-hour chart, there is a support level at 12.87, which, if violated, would cause prices to drop to 12.62. In the upper region, resistance lies at 13.54. The next price resistance is at 13.95. RSI (Relative Strength Index) is 34.51 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.72, which suggests the price will decrease in the coming days. Percent R is at 94.79%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Most Popular